The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1816-1825

  Fu, Li ^a   Hazes, Bart ^a   Burshtyn, Deborah N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODIES, NEUTRALIZING; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, KIR2DL1; RECEPTORS, KIR3DL1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 80051951883     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002125     Document Type: Article

References (33)

1. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220. (Pubitemid 29241123)
2. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640. (Pubitemid 33043908)
3. Degli-Esposti, M. A., and M. J. Smyth. 2005. Close encounters of different kinds: Dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5: 112-124. (Pubitemid 40208901)
4. Colucci, F., J. P. Di Santo, and P. J. Leibson. 2002. Natural killer cell activation in mice and men: Different triggers for similar weapons? Nat. Immunol. 3: 807-813.
5. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
6. Middleton, D., and F. Gonzelez. 2010. The extensive polymorphism of KIR genes. Immunology 129: 8-19.
7. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182: 605-609.
8. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
9. Fan, Q. R., E. O. Long, and D. C. Wiley. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2: 452-460. (Pubitemid 33706144)
10. Maenaka, K., T. Juji, D. I. Stuart, and E. Y. Jones. 1999. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure 7: 391-398. (Pubitemid 29190473)
11. Fan, Q. R., L. Mosyak, C. C.Winter, N.Wagtmann, E. O. Long, and D. C. Wiley. 1997. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389: 96-100. (Pubitemid 27387699)
12. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671. (Pubitemid 29302919)
13. Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39: 733-740. (Pubitemid 46848586)
14. Khakoo, S. I., R. Geller, S. Shin, J. A. Jenkins, and P. Parham. 2002. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 196: 911-921.
15. Rojo, S., N. Wagtmann, and E. O. Long. 1997. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27: 568-571. (Pubitemid 27085265)
16. Sharma, D., K. Bastard, L. A. Guethlein, P. J. Norman, N. Yawata, M. Yawata, M. Pando, H. Thananchai, T. Dong, S. Rowland-Jones, et al. 2009. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J. Immunol. 183: 4569-4582.
17. Sanjanwala, B., M. Draghi, P. J. Norman, L. A. Guethlein, and P. Parham. 2008. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J. Immunol. 181: 6293-6300.
18. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919. (Pubitemid 37098663)
19. Borszcz, P. D., M. Peterson, L. Standeven, S. Kirwan, M. Sandusky, A. Shaw, E. O. Long, and D. N. Burshtyn. 2003. KIR enrichment at the effector-target cell interface is more sensitive than signaling to the strength of ligand binding. Eur. J. Immunol. 33: 1084-1093. (Pubitemid 36546697)
20. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85: 227-231.
21. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1100.
22. Miller, R. G., and M. Dunkley. 1974. Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell. Immunol. 14: 284-302.
23. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3: 801-809. (Pubitemid 26092193)
24. Winter, C. C., and E. O. Long. 2000. Binding of soluble KIR-Fc fusion proteins to HLA class I. Methods Mol. Biol. 121: 239-250.
25. Cella, M., A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180: 1235-1242.
26. Kollnberger, S., A. Chan, M. Y. Sun, L. Y. Chen, C. Wright, K. di Gleria, A. McMichael, and P. Bowness. 2007. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur. J. Immunol. 37: 1313-1322. (Pubitemid 46925315)
27. Shiroishi, M., K. Kuroki, T. Ose, L. Rasubala, I. Shiratori, H. Arase, K. Tsumoto, I. Kumagai, D. Kohda, and K. Maenaka. 2006. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281: 10439-10447. (Pubitemid 43864583)
28. Shiroishi, M., K. Kuroki, L. Rasubala, K. Tsumoto, I. Kumagai, E. Kurimoto, K. Kato, D. Kohda, and K. Maenaka. 2006. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc. Natl. Acad. Sci. USA 103: 16412-16417. (Pubitemid 44715210)
29. Chapman, T. L., A. P. Heikeman, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11: 603-613.
30. Gumperz, J. E., J. C. Paterson, V. Litwin, N. Valiante, L. L. Lanier, P. Parham, and A. M. Little. 1996. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor. Tissue Antigens 48: 278-284. (Pubitemid 26377567)
31. Vilches, C., and P. Parham. 2002. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20: 217-251. (Pubitemid 34293425)
32. Rajagopalan, S., and E. O. Long. 1998. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. J. Immunol. 161: 1299-1305. (Pubitemid 28380557)
33. Robinson, J., K. Mistry, H. McWilliam, R. Lopez, and S. G. Marsh. 2010. IPD - the Immuno Polymorphism Database. Nucleic Acids Res. 38(Database issue): D863-D869.